Literature DB >> 9504521

Tamoxifen-induced fatty liver in patients with breast cancer.

Y Ogawa, Y Murata, A Nishioka, T Inomata, S Yoshida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9504521     DOI： 10.1016/S0140-6736(05)78493-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  24 in total

1.  Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency.

Authors:  T Ichikawa; K Hamasaki; H Ishikawa; E Ejima; K Eguchi; K Nakao
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

2.  A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.

Authors:  Masato Fujii; Yuichiro Shibazaki; Kyoko Wakamatsu; Yutaka Honda; Yusuke Kawauchi; Kenji Suzuki; Somasundaram Arumugam; Kenichi Watanabe; Takafumi Ichida; Hitoshi Asakura; Hiroyuki Yoneyama
Journal:  Med Mol Morphol       Date:  2013-02-22       Impact factor: 2.309

3.  Genetic and hormonal control of hepatic steatosis in female and male mice.

Authors:  Frode Norheim; Simon T Hui; Emre Kulahcioglu; Margarete Mehrabian; Rita M Cantor; Calvin Pan; Brian W Parks; Aldons J Lusis
Journal:  J Lipid Res       Date:  2016-11-03       Impact factor: 5.922

Review 4.  The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.

Authors:  Beibei Xu; Dragana Lovre; Franck Mauvais-Jarvis
Journal:  J Diabetes Complications       Date:  2017-01-20       Impact factor: 2.852

5.  An Integrative Pathway-based Clinical-genomic Model for Cancer Survival Prediction.

Authors:  Xi Chen; Lily Wang; Hemant Ishwaran
Journal:  Stat Probab Lett       Date:  2010-09-07       Impact factor: 0.870

Review 6.  The Estrogen Receptor α-Cistrome Beyond Breast Cancer.

Authors:  Marjolein Droog; Mark Mensink; Wilbert Zwart
Journal:  Mol Endocrinol       Date:  2016-08-04

Review 7.  Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Authors:  M G Curtis
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 8.  Drug-induced steatohepatitis.

Authors:  Vaishali Patel; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2013-09-04       Impact factor: 6.126

9.  Fatty metamorphosis of the liver in patients with breast cancer: possible associated factors.

Authors:  Cheng-Hsin Chu; Shee-Chan Lin; Shou-Chuan Shih; Chin-Roa Kao; Sun-Yen Chou
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice.

Authors:  Tetsu Egawa; Katsumi Toda; Yoshihisa Nemoto; Masafumi Ono; Naoaki Akisaw; Toshiji Saibara; Yoshihiro Hayashi; Makoto Hiroi; Hideaki Enzan; Saburo Onishi
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.